A case of unresectable rectal cancer with severe pelvic infiltration responding to FOLFOX
Yamazoe, S.; Yamaguchi, K.; Terasawa, H.; Ojima, T.; Tsujimura, H.; Shimomura, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(1): 125-128
2011
ISSN/ISBN: 0385-0684 PMID: 21368473 Document Number: 655168
The patient was a 54-year-old male with a huge advanced rectal cancer tumor. Abdominal CT showed liver metastasis and local progressive cancer of the rectum measuring 13 × 9 × 7 cm in diameter, which invaded the urinary bladder and sacrum. We established a diagnosis of unresectable rectal cancer and then performed sigmoid colostomy. After 16 courses of FOLFOX4, abdominal CT revealed the liver metastases to have disappeared, and the large-sized advanced rectal cancer had also remarkably decreased in size. Consequently, the patient underwent a resection of the rectum while his bladder was preserved. For 2 years 10 months after surgery, no local recurrence or distant metastasis has been observed, and the patient has received no postoperative chemotherapy. FOLFOX may therefore be a useful preoperative chemotherapy for the patients with unresectable primary rectal cancer.